|
|
||||||||
1 Department of Veterinary Comparative Anatomy, Pharmacology, and Physiology, Washington State University, Pullman, Washington 99164; and 2 Division of Neuroscience, Oregon Regional Primate Research Center, Oregon Health Sciences University, Beaverton, Oregon 97006
| |
ABSTRACT |
|---|
|
|
|---|
During lactation there are many dramatic alterations in the hypothalamic-pituitary (HP) axis, as well as an increased demand for food and water. The renin-angiotensin system (RAS) is one of the major mediators of the HP axis. This study examined the receptors for ANG II in the rat brain during lactation and diestrus. Compared with diestrus, lactating rats had significant decreases in ANG II receptor binding in several forebrain regions, most notably in the arcuate nucleus/median eminence, dorsomedial hypothalamic nucleus (DMH), and lateral hypothalamic area (LHA). In contrast, there was an increase in ANG II receptor binding in the preoptic area during lactation. These significant changes in ANG II binding in the brain during lactation support the hypothesis that changes in the RAS may contribute to the dramatic changes in the HP axis during lactation. In addition, the significant reduction in ANG II binding in the DMH and LHA may be indicative of a role in the regulation of food intake, a function only recently associated with the RAS.
arcuate nucleus; preoptic area; food intake; prolactin; hypothalamic-pituitary axis
| |
INTRODUCTION |
|---|
|
|
|---|
ANGIOTENSIN II (ANG II), the active octapeptide hormone of the brain renin-angiotensin system (RAS), can have profound actions on many of the systems that make up the hypothalamic-pituitary (HP) axis (12, 13). ANG II has a gonadal steroid-dependent modulation of gonadotropin-releasing hormone (GnRH) (39) release with a subsequent change in pituitary luteinizing hormone (LH) release (12, 38). This control is likely mediated through activation of ANG II receptors in the preoptic-anterior hypothalamic area and the ventral portion of the bed nucleus of the stria terminalis (BSTV) (16, 38). ANG II is believed to regulate fluid and electrolyte balance through activation of ANG II receptors in the subfornical organ (SFO) (25, 28), a function that may also involve an angiotensinergic projection to the paraventricular nucleus of the hypothalamus (PVH) (27). ANG II also plays an important role in stress responses through activation of receptors within the PVH that stimulate corticotropin-releasing hormone (CRH) release and mRNA expression (3, 40), as well as activation of the autonomic division of the PVH, resulting in an increased sympathetic outflow (19). Finally, ANG II stimulates dopamine (DA) release into the portal blood system through activation of receptors on dopaminergic neurons and nerve terminals within the arcuate nucleus (ARH) and median eminence (ME), respectively, resulting in inhibition of prolactin (Prl) release (20, 29).
The state of lactation is characterized by dramatic changes in the HP axis. The lactating rat has suckling-induced anovulation, resulting from near-undetectable levels of LH release from the pituitary and inhibition of ovarian cyclicity (1, 11). The suckling stimulus from the rat pups drives an increase in Prl release, which involves, at least in part, a suppression of tuberoinfundibular dopamine (TIDA) neural activity in the ARH (18, 24, 43). The lactating rat also displays a large increase in food and water intake to compensate for the fluid and energy demand of milk production. The mechanism leading to the increase in water intake is poorly understood; however, the increase in food intake is probably driven by changes in orexigenic and satiety factors, such as neuropeptide Y (NPY), agouti-related peptide, and proopiomelanocortin, in the ARH and dorsomedial hypothalamic nucleus (DMH) (2, 24, 26, 31). Lactation is also characterized by an overall reduction in the responsiveness to stress (9, 41), likely a result of altered CRH expression or activity in the PVH.
Because of the overlap between the centrally mediated role of ANG II to alter stress responses, reproductive hormone secretion, and Prl release and the dramatic changes in the HP axis during lactation, alterations in the brain RAS may be a mediating factor in one or more of these changes. One of the indicators of changes in sensitivity to any hormone is a change in the density of hormone binding sites. Therefore, the purpose of this study was to determine whether changes in the expression of brain ANG II receptor binding occur during lactation. Special attention was directed to ANG II binding in forebrain regions associated with the regulation of the HP axis.
| |
METHODS |
|---|
|
|
|---|
Animals and treatments. Pregnant (gestation day 18) and virgin cycling female rats (B&K Universal, Kent, WA) were received and housed individually on a 12:12-h light-dark cycle (lights on at 0700), with food and water available ad libitum. All animal procedures described in this paper were approved by the Oregon Regional Primate Research Center Institutional Animal Care and Use Committee. The day of delivery was considered day 0 postpartum. Litters were adjusted to eight pups on day 2 or 3 postpartum to allow for equivalent suckling stimuli and milk production. Vaginal swabs were taken daily and smears were examined microscopically to verify cyclicity in the virgin female rats. Each group contained 8-10 animals.
The rats were killed by decapitation on postpartum
day
10 or
11 for the lactating rats and on
diestrus for the cycling female rats. The brains were removed, frozen
on crushed dry ice, and stored at
80°C until processed for
in vitro receptor autoradiography. The brains were placed at
20°C 24-48 h before cryostat sectioning.
Receptor autoradiography. Rat brains
were sectioned coronally in a cryostat at 20-µm thickness and
thaw-mounted onto gelatin-coated slides. The sections were allowed to
dry at room temperature and then stored at
80°C until the
time of autoradiography.
Brain sections were thawed at ambient temperature (22-25°C) and preincubated in assay buffer (in mM: 150 NaCl, 1 EDTA, 0.1 bacitracin, and 50 sodium phosphate buffer at pH 7.2) for 30 min. Sections were then incubated in the same buffer containing 500 pM 125I-labeled Sar1,Ile8 ANG II (125I-SI ANG II) for 2 h. The sections were rinsed by dipping them in two changes of distilled water, placing them for 1 min each into five changes of assay buffer, and again dipping in two changes of distilled water. The preincubation, incubation, and rinses were all carried out at ambient temperature (22-25°C). Immediately after rinsing, the sections were dried under a stream of cool air.
Nonspecific binding was determined by incubating brain sections in the 125I-SI ANG II solution to which 3 µM ANG II had been added. Slides with radiolabeled tissue sections were mounted onto cardboard along with calibrated 125I microscale standards (Amersham; Arlington Heights, IL), and apposed to X-ray film (Kodak, SB-5) for ~3 days. Films were developed in D-19 developer (Kodak) for 2 min at 20°C and fixed for 5 min in Kodak fixer.
Image analysis. The film images of 125I binding to specific regions in the brain sections were evaluated for optical density to determine the amount of ANG II receptors in various brain regions. Films were evaluated using a Sony CCD video camera and an MCID M1 image analysis system (Imaging Research, St. Catherines, Ontario, Canada). Optical density readings were converted to units of fmol of 125I-SI ANG II bound per gram tissue wet weight (37), calibrated with 125I standards.
Images of brain sections were captured on a video monitor, and the desired nuclei were sampled for receptor density. The area sampled within each nucleus was measured for receptor density above an arbitrary computer-generated threshold level that enabled the irregular shape of the nucleus of interest to be completely sampled. Densitometric readings were made using a coding system to mask the group identity of the brains until the data were analyzed. At least two densitometric readings were obtained for each brain nucleus for each brain, and the average value was determined. The averages of the values for each nucleus were then included in the data set for statistical analysis. The size of the area sampled for each nucleus was also determined. If the average area of ANG II binding sampled for a nucleus in one group was >20% from the mean of the other group, brains whose nuclei had the highest or lowest sampling areas were resampled to adjust the area sampled to meet the arbitrary sample criterion. If there was damage to the brain section corresponding to the region of interest, values for that brain region were not included in the final data analysis. The density of 125I-SI ANG II binding between the two groups was compared by Student's t-test. The level of significance was P < 0.05.
It should be noted that values reported are for a single, subsaturating concentration of 125I-SI ANG II and do not represent maximal or even near-maximal binding density. Based on values reported by Rowe et al. (34), the average dissociation constant (KD) value for 125I-SI ANG II in predominantly AT1 receptor-containing regions of the rat brain is 665 pM. In predominantly AT2 receptor-containing regions, the average KD is 2,409 pM. Thus at predominantly AT1 receptor-containing brain regions, the 125I-SI ANG II binding at 500 pM represents ~43% of maximal AT1 receptor density. Where L = radioligand concentration: %maximal receptor density = L/(L + KD). At predominantly AT2 receptor-containing brain regions (34), the 125I-SI ANG II binding reflects ~17% of maximal AT2 receptor density.
Angiotensin receptor subtyping was not performed in this study due to the predominance of a single receptor subtype in most of the brain nuclei studied. In fact, nearly all of the brain regions studied, with the exception of the subthalamic nucleus (STN), contain almost exclusively AT1 subtype receptor binding (4, 34) and mRNA (22). The STN expresses almost exclusively AT2 receptor binding and mRNA (4, 22, 34).
| |
RESULTS |
|---|
|
|
|---|
Perihypothalamic nuclei. Six of the
eleven perihypothalamic areas studied showed significant differences in
125I-SI ANG II binding between
lactation and diestrus (Table 1). There was
a significant decrease in 125I-SI
ANG II binding in the SFO (27%), suprachiasmatic nucleus (29%; Fig.
1, C and
D), ARH/ME (33%; Fig. 1,
G and
H), DMH (27%; Fig. 1,
E and
F), and lateral hypothalamic area
(LHA; 23%; Fig. 1, E and
F) during lactation compared with
the diestrus. In contrast, there was a significant increase in
125I-SI ANG II binding in the
preoptic area (POA; 36%) in the lactating rat compared with the
diestrous rat (Fig. 1, A and
B). The area sampled as the POA
consists of ANG II binding in many nuclei. However, binding appeared to
increase in the whole region of the POA; therefore, it was sampled as a
whole. The BSTV also showed a trend toward a decrease in
125I-SI ANG II binding density
(21%) in the lactating rat; however, the difference did not reach
significance (P = 0.083). Other areas, including the ventral lateral diagonal band of Broca, median preoptic nucleus, and PVH, displayed no difference in binding density between the two groups.
|
|
Other nuclei. The nucleus of the lateral olfactory tract (Fig. 1, C and D) and the STN also displayed significant decreases in 125I-SI ANG II binding density in the lactating rat compared with the diestrous rat: 37% and 23%, respectively (Table 1). The piriform cortex (PC) displayed a near-significant decrease in binding density (30%, P = 0.059) in the lactating rat, whereas the ventral subiculum displayed no significant difference in binding density between the two groups.
| |
DISCUSSION |
|---|
|
|
|---|
Lactation in the rat is characterized by dramatic changes in the HP axis, as well as a more than doubling in food and water intake, compared with nonlactating rats (30). All of these physiological changes are necessary for the successful rearing of the pups. The RAS is a well-characterized regulator of several HP axis systems, as well as fluid and electrolyte balance. Therefore, changes in ANG II receptor expression in the hypothalamus during lactation could potentially explain some of the physiological changes that occur in this reproductive state.
Prl secretion is critical for milk production. In view of the demonstrated ability of brain ANG II to inhibit Prl secretion via stimulation of DA neuronal activity and release (20, 29) from the ARH and ME, respectively, successful milk production during lactation may entail a reduction in ANG II-mediated DA release from these regions. Therefore, the significant decrease in ANG II binding in ARH of the lactating rat (Table 1; Fig. 1, G and H) is expected and may be at least partially responsible for the decrease in TIDA neuronal activity during lactation (18, 24, 43). Although the ARH and ME were sampled together, it was evident that ANG II binding decreased in the lactating rat in both of these regions (Fig. 1, E-H). ANG II likely plays a role in the release of several hormones into the portal blood system (including GnRH, CRH, and/or DA) through activation of its receptors in the ME. In addition, ANG II receptor expression in the ARH and ME have been shown to be dependent on the presence of gonadal steroids, with ANG II receptors being highest when estrogen and progesterone are elevated (20, 35). The low levels of ANG II binding in these regions observed in this study are consistent with the low levels of estrogen during lactation.
Centrally administered ANG II has been shown to have a gonadal steroid-dependent action on LH release, with ANG II stimulating LH release in estrogen- and progesterone-treated ovariectomized (OVX) rats and inhibiting LH release in the untreated OVX rat (12, 38). Although the location of the ANG II receptors responsible for these actions on LH release is unknown, it is probable that ANG II receptors in brain regions containing estrogen and progesterone receptors, such as the POA, diagonal band of Broca, and BSTV (4, 16), play a role. The present data support this hypothesis, demonstrating a significant increase in ANG II receptor binding in the POA during lactation (Table 1; Fig. 1, A and B). Because the lactating rat is characterized as having nearly undetectable levels of estrogen, it is expected that ANG II would have an inhibitory effect on LH release. Therefore, the increase in ANG II binding in this region may be indicative of an increased inhibitory tone on GnRH neural activity. The stimulus driving the increase in ANG II receptors in this region remains unknown; however, pup suckling has been shown to stimulate expression of the immediate early gene c-Fos in this region (23), indicating an increase in neural activity (18). This area also contains a large population of GABA neurons, which may mediate the inhibitory actions of ANG II on GnRH neural activity.
Given the changes in the HP axis and the dramatic increase in water intake during lactation, it was hypothesized that there may be an increase in ANG II binding in the two major dipsogenic centers, the PVH and SFO. Surprisingly, there was no difference in ANG II binding in the PVH between lactation and diestrus (Table 1). In addition, the SFO actually displayed a significant decrease in ANG II binding during lactation (Table 1). However, because the level of ANG II is unknown during lactation, it is difficult to anticipate whether the lack of a change in ANG II binding in the PVH represents no change in angiotensinergic activity or whether the decrease in binding in the SFO actually represents a decrease in function. The potential change in brain ANG II levels will be discussed below. The reason for a lack of an increase in ANG II binding in these two dipsogenic control centers is unknown.
The role of ANG II in the DMH and LHA is not well defined; however, both brain regions are associated with regulation of food intake and body weight. The orexigenic peptide NPY is expressed in the DMH specifically during lactation, in a model of hyperphagia, and in specific genetic models of obesity (21, 24). The LHA is also a region that expresses numerous modulators of food intake, such as orexin, melanin-concentrating hormone, and CRH (see review, Ref. 10). Although ANG II is not classically associated with the regulation of food intake or body weight, two recent studies (6, 8) have demonstrated that chronic systemic ANG II administration caused a significant decrease in body weight. In addition, Brink et al. (6) reported that the decrease in body weight was directly associated with a decrease in food intake. Both the decreases in body weight and food intake occurred independently of the increase in blood pressure (6, 8). The mechanism by which systemic administration of ANG II causes a decrease in food intake is unknown. However, ANG II is a potent stimulator of CRH release, which is a known inhibitor of food intake (5, 32). In the present study, we demonstrate that ANG II receptor binding significantly decreases in the DMH and LHA during lactation (Table 1; Fig. 1, E and F), suggesting a possible decrease in angiotensinergic-associated hypophagia during lactation. The PC, which processes olfactory sensory information (36), also plays a role in the modulation of dietary amino acid intake, a function involving the noradrenergic system (14, 15). Interestingly, our group recently demonstrated that ANG II receptor binding in the PC was significantly reduced by lesioning of the medial forebrain bundle (17), the major brain stem noradrenergic projection to the forebrain. Therefore, the decline in ANG II binding in the PC of the lactating rat, although not reaching a significance of P < 0.05 (Table 1), may suggest a decrease in noradrenergic neurotransmission within this region, and subsequently a change in food intake. Further study is needed to investigate the potential role of ANG II in the regulation of food intake and the potential interactions between ANG II and orexigenic and satiety factors in these regions.
It is unknown what the endogenous levels of ANG II are in the plasma or brain of the lactating rat. Therefore, it is unknown whether the changes in ANG II receptor binding density are a result of homologous regulation caused by changes in ANG II levels or a direct result of the change in steroid environment. The lactating rat has elevated basal levels of glucocorticoids (42), which generally have a stimulatory effect on angiotensinogen (AON) mRNA expression in most regions of the brain (7, 33). However, there are some specific regions that display neither regulation by glucocorticoids nor even an inhibitory effect (7). The lactating rat is, therefore, likely to have region-specific changes in AON levels. Thus it is important to further investigate the levels of AON mRNA expression, as well as the enzymes responsible for the production of the active octapeptide, during lactation to determine the extent to which angiotensinergic function is modulated in this model.
Perspectives
These results indicate that the mechanisms leading to the suppression of reproductive function, hyperphagia, and hyperprolactemia during lactation may involve changes in brain ANG II receptor expression. This study constitutes just the first step necessary to determine the extent to which the brain RAS is involved in this naturally altered physiological state. In addition, nothing is known about the signal(s) driving the changes in receptor expression in the various regions, i.e., the suckling stimulus, hyperprolactemia, negative energy balance, and/or elevated basal corticosterone levels. It is well known that in response to various physiological stresses (i.e., negative energy balance and neurological stresses), reproductive function is usually the first system to be disrupted. Thus it makes physiological sense to have a neuropeptide system, such as ANG II, intricately involved in stress responsivity to function as a "systems status check" that can modulate reproductive neuroendocrine function.| |
ACKNOWLEDGEMENTS |
|---|
The authors thank Dr. Rebecca Brogan for critical review of this manuscript.
| |
FOOTNOTES |
|---|
This research was supported by the Peptide Radioiodination Service Center, Washington State University, a Howard Hughes Medical Institute Undergraduate Research Fellowship (to W. T. Barry), and National Institutes of Health grants HD-14643 and RR-00163.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: K. L. Grove, Division of Neuroscience, Oregon Regional Primate Research Center, Oregon Health Sciences Univ., 505 NW 185th Ave, Beaverton, OR 97006-3499 (E-mail: grovek{at}OHSU.edu).
Received 18 February 1999; accepted in final form 17 May 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Abbud, R.,
and
M. S. Smith.
Differences in the luteinizing hormone and prolactin response to multiple injections of kainate, compared with N-methyl-D,L-aspartate, in cycling rats.
Endocrinology
129:
3254-3258,
1991[Abstract].
2.
Abizaid, A.,
C. Walker,
and
B. Woodside.
Changes in neuropeptide Y immunoreactivity in the arcuate nucleus during and after food restriction in lactating rats.
Brain Res.
761:
306-312,
1997[Medline].
3.
Aguilera, G.,
W. S. Young,
A. Kiss,
and
A. Bathia.
Direct regulation of hypothalamic corticotropin-releasing-hormone neurons by angiotensin II.
Neuroendocrinology
61:
437-44,
1995[Medline].
4.
Allen, A. M.,
G. Paxinos,
and
F. A. O. Mendelsohn.
Localization of angiotensin II receptor binding sites in the rat brain.
In: Handbook of Chemical Neuroanatomy, edited by A. Bjorklund,
T. Hokfelt,
and M. J. Kuhar. Amsterdam: Elsevier, 1992, p. 1-37.
5.
Bornstein, S. R.,
E. L. Webster,
D. J. Torpy,
S. J. Richman,
N. Mitsiades,
M. Igel,
D. B. Lewis,
K. C. Rice,
H.-G. Joost,
M. Tsokos,
and
G. P. Chrousos.
Chronic effects of a nonpeptide CRH type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation.
Endocrinology
139:
1546-1555,
1998
6.
Brink, M.,
J. Wellen,
and
P. Delafontaine.
Angiotensin II causes weight loss and decreases circulating insulin-like growth factor 1 in rats through pressor-independent mechanism.
J. Clin. Invest.
97:
2509-2516,
1996[Medline].
7.
Bunnemann, B.,
A. Lippoldt,
J. A. Aguirre,
A. Cintra,
and
R. Metzger.
Glucocorticoid regulation of angiotensinogen gene expression in discrete areas of the male rat brain.
Neuroendocrinology
57:
856-862,
1993[Medline].
8.
Cassis, L. A.,
D. E. Marshall,
M. J. Fettinger,
B. Rosenbluth,
and
R. A. Lodder.
Mechanisms contributing to angiotensin II regulation of body weight.
Am. J. Physiol.
274 (Endocrinol. Metab. 37):
E867-E876,
1998
9.
Da Costa, A. P. C.,
S. Wood,
C. D. Ingram,
and
S. L. Lightman.
Region-specific reduction in stress-induced c-fos mRNA expression during pregnancy and lactation.
Brain Res.
742:
177-184,
1996[Medline].
10.
Flier, J. S.,
and
E. Maratos-Flier.
Obesity and the hypothalamus: novel peptides for new pathways.
Cell
92:
437-440,
1998[Medline].
11.
Fox, S. R.,
and
M. S. Smith.
The suppression of pulsatile luteinizing hormone secretion during lactation in the rat.
Endocrinology
115:
2045-2051,
1984[Abstract].
12.
Ganong, W. F.
Blood, pituitary, and brain renin-angiotensin systems and regulation of secretion of anterior pituitary gland.
Front. Neuroendocrinol.
14:
233-249,
1993[Medline].
13.
Ganong, W. F.
Reproduction and the renin-angiotensin system.
Neurosci. Biobehav. Rev.
19:
241-250,
1995[Medline].
14.
Gietzen, D. W.,
and
M. Jhanwar-Uniyal.
Alpha 2 noradrenoceptors in the anterior piriform cortex decline with acute amino acid deficiency.
Mol. Brain Res.
35:
41-46,
1996[Medline].
15.
Gietzen, D. W.,
P. M. Leung,
and
Q. R. Rogers.
Norepinephrine and amino acids in prepyriform cortex of rats fed imbalanced amino acid diets.
Physiol. Behav.
36:
1071-1080,
1986[Medline].
16.
Grove, K. L.,
V. I. Cook,
and
R. C. Speth.
Angiotensin II receptors in the ventral portion of the bed nucleus of the stria terminalis.
Neuroendocrinology
53:
339-343,
1991[Medline].
17.
Grove, K. L.,
R. C. Speth,
A. A. Palmer,
W. F. Ganong,
and
M. K. Steele.
Angiotensin II receptor binding sites in the ventral portion of the bed nucleus of the stria terminalis are reduced by interruption of the medial forebrain bundle.
Brain Res.
809:
5-11,
1998[Medline].
18.
Hoffman, G. E.,
W. W. Le,
R. Abbud,
W. S. Lee,
and
M. S. Smith.
Use of Fos-related antigens (FRAs) as markers of neuronal activity: FRA changes in dopamine neurons during proestrus, pregnancy and lactation.
Brain Res.
654:
207-215,
1994[Medline].
19.
Jezova, D.,
T. Ochedalski,
A. Kiss,
and
G. Aguilera.
Brain angiotensin II modulates sympathoadrenal and hypothalamic pituitary adrenocortical activation during stress.
J. Neuroendocrinol.
10:
67-72,
1998[Medline].
20.
Johren, O.,
G. L. Sanvitto,
G. Egidy,
and
J. M. Saavedra.
Angiotensin II AT1A receptor mRNA expression is induced by estrogen-progesterone in dopaminergic neurons of the female rat arcuate nucleus.
J. Neurosci.
17:
8283-8292,
1997
21.
Kesterson, R. A.,
D. Huszar,
C. A. Lynch,
R. B. Simerly,
and
R. D. Cone.
Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the Agouti obesity syndrome.
Mol. Endocrinol.
11:
630-637,
1997
22.
Lenkei, Z.,
M. Palkovits,
P. Corvol,
and
C. Llorens-Cortes.
Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult brain: a functional neuroanatomical review.
Front. Neuroendocrinol.
18:
383-439,
1997[Medline].
23.
Li, C., P. Chen, and M. S. Smith. Neural
populations in the rat forebrain and brainstem activated by the
suckling stimulus as demonstrated by CFOS expression.
Neuroscience. In press.
24.
Li, C.,
P. Chen,
and
M. S. Smith.
Neuropeptide Y and tuberoinfundibular dopamine activities are altered during lactation: role of PRL.
Endocrinology
140:
118-123,
1999
25.
Lind, R. W.,
L. W. Swanson,
and
D. Ganten.
Angiotensin II immunoreactivity in the neural afferents and efferents of the subfornical organ of the rat.
Brain Res.
321:
209-215,
1984[Medline].
26.
Mann, P. E.,
B. S. Rubin,
and
R. S. Bridges.
Differential proopiomelanocortin gene expression in the medial basal hypothalamus of rats during pregnancy and lactation.
Mol. Brain Res.
46:
9-16,
1997[Medline].
27.
Miselis, R. R.
The efferent projections of the subfornical organ of the rat: a circumventricular organ within a neural network subserving water balance.
Brain Res.
230:
1-23,
1981[Medline].
28.
Miselis, R. R.,
R. E. Shapiro,
and
P. J. Hand.
Subfornical organ efferents to neural systems for control of body water.
Science
205:
1022-1025,
1979
29.
Mounzih, K.,
K. L. Grove,
R. C. Speth,
M. K. Steele,
and
W. F. Ganong.
Further studies of the site at which angiotensin II acts in the central nervous system to inhibit the secretion of prolactin.
Endocr. J.
2:
41-45,
1994.
30.
Ota, K.,
and
A. Yokoyama.
Body weight and food comsumption of lactating rats: effects of ovariectomy and of arrest and resumption of suckling.
J. Endocrinol.
38:
251-261,
1967[Medline].
31.
Pape, J.,
and
G. Tramu.
Suckling-induced changes in neuropeptide Y and proopiomelanocortin gene expression in the arcuate nucleus of the rat: Evaluation of a putative intervention of prolactin.
Neuroendocrinology
63:
540-549,
1996[Medline].
32.
Plamondon, H.,
and
Z. Merali.
Regulation of ingestion by CRF and bombesin-like peptides: distinct meal-related peptide level changes.
Am. J. Physiol.
272 (Regulatory Integrative Comp. Physiol. 41):
R268-R274,
1997
33.
Riftina, F.,
J. Angulo,
P. Pompei,
and
B. S. McEwen.
Regulatoin of angiotensinogen gene expression in the rat forebrain by adrenal steroids and relation to salt appetite.
Mol. Brain Res.
33:
201-208,
1995[Medline].
34.
Rowe, B. P.,
D. L. Saylor,
and
R. C. Speth.
Analysis of angiotensin II receptor subtypes in individual rat brain nuclei.
Neuroendocrinology
55:
563-573,
1992[Medline].
35.
Seltzer, A.,
K. Tsutsumi,
K. Shigematsu,
and
J. M. Saavedra.
Reproductive hormones modulate angiotensin AT1 receptors in the dorsomedial arcuate nucleus of the female rat.
Endocrinology
133:
939-941,
1993[Abstract].
36.
Shipley, M. T.,
J. H. McLean,
L. A. Zimmer,
and
M. Ennis.
The olfactory system.
In: Integrated Systems of the CNS, edited by L. W. Swanson,
A. Bjorklund,
and T. Hokfelt. Amsterdam: Elsevier, 1996, pt. III, p. 469-556.
37.
Speth, R. C.,
T. T. Dinh,
and
S. Ritter.
Nodose ganglionectomy reduces angiotensin II receptor binding in the rat brainstem.
Peptides
8:
677-685,
1987[Medline].
38.
Steele, M. K.
Effects of angiotensins injected into various brain areas on luteinizing hormone release in female rats.
Neuroendocrinology
46:
401-405,
1987[Medline].
39.
Steele, M. K.,
K. N. Stephenson,
J. M. Meredith,
and
J. E. Levine.
Effects of angiotensin II on LHRH release as measured by in vivo microdialysis of the anterior pituitary gland of conscious female rats.
Neuroendocrinology
55:
276-281,
1992[Medline].
40.
Sumitomo, T.,
T. Suda,
Y. Nakano,
F. Tozawa,
M. Yamada,
and
H. Demura.
Angiotensin II increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus.
Endocrinology
128:
2248-2252,
1991[Abstract].
41.
Toufexis, D. J.,
and
C. Walker.
Noradrenergic facilitation of the adrenocorticotropin response to stress is absent during lactation in the rat.
Brain Res.
737:
71-77,
1996[Medline].
42.
Walker, C.,
S. L. Lightman,
M. K. Steele,
and
M. F. Dallman.
Suckling is a persistant stimulus to the adrenocortical system of the rat.
Endocrinology
130:
115-125,
1992[Abstract].
43.
Wang, H. J.,
G. E. Hoffman,
and
M. S. Smith.
Suppressed tyrosine hydroxylase gene expression in the tuberoinfundibular dopaminergic system during lactation.
Endocrinology
133:
1657-1663,
1993[Abstract].
This article has been cited by other articles:
![]() |
R. De Matteo, G. A. Head, and D. N. Mayorov Angiotensin II in dorsomedial hypothalamus modulates cardiovascular arousal caused by stress but not feeding in rabbits Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R257 - R264. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Speth, M. S. Smith, and K. L. Grove Brain angiotensinergic mediation of enhanced water consumption in lactating rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2002; 282(3): R695 - R701. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Speth, M. S. Smith, and K. L. Grove Lactation decreases angiotensinogen mRNA expression in the midcaudal arcuate nucleus of the rat brain Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2001; 280(4): R1169 - R1176. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |